Valeant Commits $200,000 to Support Hurricane Relief Efforts


“Our thoughts and prayers are with the people of Texas, the Gulf Coast and Florida, including some of our employees, who have been impacted by these destructive storms,” said Joseph C. Papa, chairman and CEO, Valeant. “We are glad to support both the American Red Cross and Americares. Additionally, I am especially proud of the response by our employees, some of whom traveled to the affected areas to volunteer in the relief efforts.”

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Investor Contact:                                

Media Contact:

Arthur Shannon                                            

Lainie Keller

[email protected]                      

[email protected]

(514) 856-3855                                                 

(908) 927-0617

(877) 281-6642 (toll free)                     

View original content with multimedia:

SOURCE Valeant Pharmaceuticals International, Inc.

Related Links

Powered by WPeMatico